Plants of the Cannabis genus are the only producers of phytocannabinoids, terpenoid compounds 26 that strongly interact with evolutionarily ancient endocannabinoid receptors shared by most 27 bilaterian taxa. For millennia, the plant has been cultivated for these compounds, but also for 28 food, rope, paper, and clothing. Today, specialized varieties yielding high-quality textile fibers, 29 nutritional seed oil or high cannabinoid content are cultivated across the globe. However, the 30 genetic identities and histories of these diverse populations remain largely obscured. We 31 analyzed the nuclear genomic diversity among 340 Cannabis varieties, including fiber and seed 32 oil hemp, high cannabinoid drug-types and feral populations. These analyses demonstrate the 33 existence of at least three major groups of diversity, with European hemp varieties more closely 34 related to narrow leaflet drug-types (NLDT) than to broad leaflet drug-types (BLDT). The BLDT 35 group appears to encompass less diversity than the NLDT, which reflects the larger geographic 36 range of NLDTs, and suggests a more recent origin of domestication of the BLDTs. As well as 37 being genetically distinct, hemp, NLDT and BLDT genetic groups each produce unique 38 cannabinoid and terpenoid content profiles. This combined analysis of population genomic and 39 trait variation informs our understanding of the potential uses of different genetic variants for 40 medicine and agriculture, providing valuable insights and tools for a rapidly emerging, valuable 41 legal industry. 42 43 Significance Statement 44 Despite millennia of cultivation and current widespread use across the globe, Cannabis is the 45 only multi-billion dollar crop for which the genetic identities and origins of most varieties are 46 unknown. As legalized cultivation of hemp and high-cannabinoid types continues to grow 47 3 rapidly in the US and other countries, the need for a better understanding of the diversity and 48 evolution of the species has increased. Through analyzing the genomes of 340 hemp, drug and 49
THCA and CBDA are alternative products of a shared precursor, CBGA (35). A single 117 locus with co-dominant alleles was proposed to explain patterns of inheritance for THCA to CBDA 118 ratios (7, 36) . However more recent quantitative trait loci (QTL) mapping experiments (37), 119 expression studies (38) and genomic analyses (10) paint a more complex scenario with several 120 linked paralogs responsible for the various THCA and CBDA phenotypes. Other cannabinoids 121 such as cannabigerol (CBG) (39), cannabichromene (CBC) (40) and delta-9-122 tetrahydocannabivarin (THCV) (41) demonstrate pharmacological promise, and can also be 123 produced at high levels by the plan t(42-44). Additionally, Cannabis secondary metabolites such 124 as terpenoids and flavonoids likely contribute to therapeutic or psychoactive effects (2), such as β-125 myrcene, humulene and linalool proposed to produce sedative effects associated with specific 126 strains (45). 127 In this study, plants that produce low levels of total cannabinoids are herein referred to as 128 hemp, while high cannabinoid producing varietals are described as drug-type strains. Legal date have found hemp varieties are genetically distinct from drug-type strains (10), though 140 interestingly Hillig (5) found broad leaflet southeastern Asian hemp landraces to be more closely 141 related to Asian drug-type strains than to European hemp strains. 142 Cannabis has a diploid genome (2n = 20), and an XY/XX chromosomal sex-determining 143 system(48). The genome size is estimated to be 818 Mb for female plants and 843 Mb for male 144 plants (49). Currently, a draft genome consisting of 60,029 scaffolds is available for the Purple 145 Kush (PK) drug-type strain from the National Center for Biotechnology Information. Additional 146 whole genome data is available from NCBI for the Finola and USO31 hemp strains. Various 147 reduced representation genome, gene and RNA sequence data are also available from NCBI. 148 Presently Cannabis is the only multi-billion dollar legal crop without a sequence-based genetic 149 linkage or physical genome map. Indeed, the first genetic map for the species, using AFLP and 150 microsatellite markers, was only recently published, providing for the first time, quantitative trait 151 mapping of cannabinoid content and other traits (37) . 152 Initial studies of Cannabis genetic diversity examined either many samples with few 153 molecular markers (5) or whole genome wide data for relatively few samples types (10). Sawler present study is to assess the genomic diversity and phylogenetic relationships among 340 total 157 Cannabis plants that have distinct phenotypes, and that were described a priori by plant breeders 158 as various landraces, indica, sativa, hemp and drug-types, as well as commercially available 159 hemp and drug-types with unclear pedigrees. We have combined data from existing sources and 160 generated new data to create the largest sample set of Cannabis genomic sequence data 161 published to date. These data and analyses will continue to facilitate the development of were removed due to excess self-similarity (≥ 97 % identity and ≥ 500 bps length, Figure S1 ).
171
After this filter, the total single copy portion the PK reference within the combined coverage 172 levels for all 67 WGS samples of 326x -401x, a 95% Poisson confidence interval around a 362x 173 mean, was 71,236,365 bps ( Figure S1 ). After quality (Q), genotype quality (GQ), allele 174 frequency (AF), missing data, biallelic and ambiguous base filters, the following SNP counts 175 remained: 491,341 WGS, 2,894 GBS (this study), SNPs 4,105 GBS Sawler (50). Forty-five 176 SNPs overlapped both GBS datasets, and the WGS samples. represented in our samples, we first applied the FLOCK model to our data set of 195 GBS and 217 WGS Cannabis samples, which is an iterative reallocation clustering algorithm that does not 218 require non-admixed individuals to make population assignments (53). Using the K-partitioning 219 method suggested by the authors (53), we determined that K ≥ 3, after testing K values of one to 220 eight ( Table 2 and peripheral population names in Figure 2 ). FLOCK was able to assign all 221 samples to one of the three populations, although it does not calculate admixture proportions.
222
Sample population assignments were largely consistent with the known history of these samples, 223 and appear visually consistent with MDS analysis ( Figure S2 ). For example all fiber and seed oil 224 hemps were assigned to an exclusive population, with the exception of sample AC/DC, a high 225 CBDA producing variety, with likely hybrid hemp origins ( Figure 2 , Table 2 (Figure 2 , Dataset S1), shows consistent separation between BLDT and NLDT and hemp strains. reinforces the importance of using many, high-quality, single-copy regions of the genome, rather 268 than smaller numbers of loci that could lead to less resolution or even misleading results.
269
Although lore (52), Figure 2 and Figure S2 strongly suggest at least some individuals have 270 hybrid origins, these tree models for the overall SNP frequencies of the population groups 271 inferred by FLOCK (Table 2) as well as within the hemp group (Dataset S1), but rarely reach equivalent quantities total 352 cannabinoid production as those found in high THCA plants (Figure 4a) Efforts should also be made to document and preserve feral, wild and heirloom populations that 358 can serve as reservoirs of cultural and genetic diversity.
359
Aromatic terpenoids impart many of the characteristic fragrances to Cannabis, and 360 possibly contribute to the effects of consumption (2). Terpenoids are synthesized in many plant 361 species, and play a role in relieving various abiotic and biotic stresses through direct and indirect 362 mechanisms (71). Our analysis of strains sharing common genetic groups shows that each group 363 has a distinct terpenoid profile (Figure 5c and Figure S5 ). We found NLDTs to contain 364 significantly more β-myrcene and α-terpinolene than BLDTs, although interestingly the two 365 hemp strains for which we analyzed chemical data for had significantly more β-myrcene than 366 either drug-type group (Figure 5c ). Similarly Hillig (72) found NLDTs to yield significantly 367 more β-myrcene than Afghani BLDTs, yet European hemp and un-cultivated accessions labeled 368 as C. ruderalis contained the highest levels. Hillig also reported that Afghani BLDTs contained 369 the highest levels of guaiol and eudesmol isomers, which we did not measure, although we found Conclusions. Cannabis genomics offers a window into the past, but also a road forward.
384
Although historical and clandestine breeding efforts have been clearly successful in many 385 regards (21, 31), Cannabis lags decades behind other major crop species in many other respects.
386
Developing stable Cannabis lines capable of producing the full range of potentially therapeutic 387 cannabinoids is important for the research and medical communities, which currently lack access 388 to diverse high-quality material in the USA (73).
389
In this paper we extended the initial Cannabis genome study (10), by re-mapping WGS 390 and GBS sequence reads to the existing PK draft scaffolds, to understand diversity and 391 evolutionary relationships among the major lineages. Although hybridization of cultivated 392 varieties (52) and human transport of seeds across the globe was hypothesized to have obscured 393 much of the ancestral genetic signal (13), we found significant evidence for apparent ancestral 394 signals in genomic data derived largely from modern cultivated varieties ( Figure S1 ) and bounded by a 95% Poisson confidence interval (mean 362x coverage). Further 440 removal of repetitive content was achieved by aligning the PK reference to itself with BLASTN 441 and removing all sites that were within regions of ≥ 97% identity for at ≥ 500 bp alignments.
442
These aforementioned processing, alignment and SNP calling procedures were then preformed 443 separately on the 182 GBS samples generated for this study and the 143 GBS samples previously 
